A detailed history of Humankind Investments LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Humankind Investments LLC holds 5,789 shares of MRNA stock, worth $228,028. This represents 0.14% of its overall portfolio holdings.

Number of Shares
5,789
Previous 3,583 61.57%
Holding current value
$228,028
Previous $425,000 9.18%
% of portfolio
0.14%
Previous 0.11%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$63.64 - $125.14 $140,389 - $276,058
2,206 Added 61.57%
5,789 $386,000
Q2 2024

Aug 12, 2024

SELL
$101.21 - $166.61 $348,162 - $573,138
-3,440 Reduced 48.98%
3,583 $425,000
Q1 2024

May 08, 2024

SELL
$85.37 - $115.44 $52,331 - $70,764
-613 Reduced 8.03%
7,023 $748,000
Q4 2023

Feb 14, 2024

BUY
$69.51 - $104.43 $130,817 - $196,537
1,882 Added 32.71%
7,636 $759,000
Q3 2023

Nov 13, 2023

BUY
$96.41 - $126.61 $101,712 - $133,573
1,055 Added 22.45%
5,754 $594,000
Q2 2023

Aug 18, 2023

SELL
$118.5 - $160.53 $202,279 - $274,024
-1,707 Reduced 26.65%
4,699 $570,000
Q2 2023

Aug 09, 2023

BUY
$118.5 - $160.53 $502,440 - $680,647
4,240 Added 195.75%
6,406 $778,000
Q1 2023

Apr 25, 2023

BUY
$135.66 - $197.02 $29,166 - $42,359
215 Added 11.02%
2,166 $332,000
Q4 2022

Jan 26, 2023

SELL
$118.38 - $210.04 $58,124 - $103,129
-491 Reduced 20.11%
1,951 $0
Q3 2022

Nov 09, 2022

BUY
$118.07 - $194.18 $25,503 - $41,942
216 Added 9.7%
2,442 $289,000
Q2 2022

Aug 05, 2022

SELL
$117.13 - $176.59 $3,865 - $5,827
-33 Reduced 1.46%
2,226 $318,000
Q1 2022

May 09, 2022

BUY
$126.46 - $235.05 $136,703 - $254,089
1,081 Added 91.77%
2,259 $389,000
Q4 2021

Mar 21, 2022

BUY
$225.82 - $368.51 $98,909 - $161,407
438 Added 59.19%
1,178 $299,000
Q3 2021

Mar 21, 2022

SELL
$221.9 - $484.47 $74,558 - $162,781
-336 Reduced 31.23%
740 $285,000
Q2 2021

Mar 21, 2022

BUY
$129.91 - $234.98 $139,783 - $252,838
1,076 New
1,076 $253,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Humankind Investments LLC Portfolio

Follow Humankind Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Humankind Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Humankind Investments LLC with notifications on news.